Showing results (551-560 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|August 3, 2018
Open-Label, Crossover Study to Determine the Pharmacokinetics of Fluticasone Furoate and Batefenterol When Administered Alone, in Combination, or ConcurrentlyClaire Ambery, Graeme Young, Teresa Fuller, et al.
Clinical Pharmacology in Drug Development|November 21, 2022
Effect of Futibatinib on Cardiac Repolarization: Results of a Randomized, Controlled, Double-Blind, QT/QTc, Phase 1 Study in Healthy SubjectsIkuo Yamamiya, Robert Lester, Daryl Sonnichsen, et al.
Clinical Pharmacology in Drug Development|November 17, 2022
Comparability of Foslevodopa/Foscarbidopa Pharmacokinetics in Healthy Asian and White ParticipantsMatthew Rosebraugh, Melina Neenan, Maurizio Facheris
Clinical Pharmacology in Drug Development|February 22, 2023
Pharmacokinetics and Safety of Single and Multiple Daily Dosing of 75-mg Rimegepant Orally Disintegrating Tablets in Healthy Chinese Adults: A Randomized Placebo-Controlled TrialYan Li, Xinghe Wang, Alex Ballesteros-Perez, et al.
Clinical Pharmacology in Drug Development|August 22, 2025
Effects of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SPH3348: A Single-Center, Randomized, Open-Label, Single-Dose, 2-Period, 2-Sequence Crossover StudyZhuo Chen, Qin Yu, Shiyin Feng, et al.
Clinical Pharmacology in Drug Development|August 28, 2021
Pharmacokinetic and Bioequivalence Evaluation of 2 Tadalafil Tablets in Healthy Male Chinese Subjects Under Fasting and Fed ConditionsRong Shao, Dan-Dan Yang, Zou-Rong Ruan, et al.
Clinical Pharmacology in Drug Development|November 12, 2022
Pharmacokinetics of the Multi-kinase Inhibitor Pexidartinib: Mass Balance and Dose ProportionalityHamim Zahir, Jonathan Greenberg, Ching Hsu, et al.
Clinical Pharmacology in Drug Development|March 2, 2023
First-in-Human, Single- and Multiple-Ascending-Dose, Food-Effect, and Absolute Bioavailability Trials to Assess the Pharmacokinetics, Safety, and Tolerability of Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor Against Herpes Simplex Virus in Healthy SubjectsDirk Kropeit, Susanne Bonsmann, Oliver von Richter, et al.
Clinical Pharmacology in Drug Development|January 28, 2023
A Randomized, Double-Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy VolunteersJimin Lee, Robert Lester, Terry O'Reilly, et al.
Clinical Pharmacology in Drug Development|January 28, 2023
Clinical Impact of Antipolyethylene Glycol (PEG) Antibody in Hematological Patients Administered PEGylated-Granulocyte Colony-Stimulating FactorNaoto Okada, Shimizu Taro, Hidenori Ando, et al.
Pageof 136